Treace Medical Concepts Inc

Treace Medical Concepts Inc

TMCI - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$277.7M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Treace Medical Concepts IncTreace Medical Concepts Inc-4.6--88%1.50.2
$-1.35

Current Fair Value

130.6% downside

Overvalued by 130.6% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$277.70 Million
Enterprise Value$278.18 Million
Earnings per Share$-0.93
Beta1.49
Outstanding Shares65,049,844

Return

Return on Equity-87.86%ROE
Return on Assets-32.87%
Return on Invested Capital-40.02%

Valuation & Multiples

P/E Ratio-4.59P/E Ratio
PEG52.38PEG
Price to Sales1.47Price to Sales
Price to Book Ratio4.42Price to Book Ratio
Enterprise Value to Revenue1.35
Enterprise Value to EBIT-4.98
Enterprise Value to Net Income-5
Total Debt to Enterprise0.05
Debt to Equity0.19Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 7, 2026
EPS Estimate
$-0.30
Consensus analyst estimate
Revenue Estimate
$44.02 M
Consensus analyst estimate

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$-0.26
Consensus analyst estimate
Revenue Estimate
$47.80 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls105,500▲ Infinity%
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %49.41%▼ 6.30%
Total Invested$127.94M▲ 164.88%
Investors Holding122▲ 5.00%

About Treace Medical Concepts Inc

133 employees

Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The Company’s patented Lapiplasty® 3D Bunion ...

Treace Medical Concepts Insider Information FAQ

Stockcircle tracks 4 top investors with a current 13F position in Treace Medical Concepts. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 2 top investors increased or opened positions and 2 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 14 open-market insider purchases for Treace Medical Concepts in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.